Botella Lucena P, Vanherle S, Lodder C, Gutierrez de Rave M, et al. Blood-based Abeta42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention. Acta Neuropathol 2022;144:489-508.
PMID: 35796870